• 1
    Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 1997; 113(Suppl.): S11348.
  • 2
    Fennerty MB. What are the treatment goals for Helicobacter pylori infection? Gastroenterology 1997; 113(Suppl.): S1205.
  • 3
    Pounder RE. New developments in Helicobacter pylori eradication therapy. Scand J Gastroenterol 1997; 32(Suppl.): 435.
  • 4
    Treiber G. The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. Am J Gastroenterol 1996; 91: 24657.
  • 5
    Hulten K, Cars O, Hjelm E & Engstrand L. In vitro activity of azithromycin against intracellular Helicobacter pylori. J Antimicrob Chemother 1996; 37: 4839.
  • 6
    Megraud F, Darmaillac V & Brugmann D. Helicobacter pylori and azithromycin. Pathologie Biologie 1995; 43: 55560.
  • 7
    Di Mario F, Dal Bo N & Grassi SA, et al. Azithromycin for the cure of Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 2647.
  • 8
    Al-Assi MT, Genta RM & Karttunen TJ, et al. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol 1995; 90: 4035.
  • 9
    Caselli M, Trevisani L & Tursi A, et al. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997; 9: 458.
  • 10
    Di Febo G, Calabrese C & Brandi G, et al. A new triple association of azithromycin, lansoprazole and tinidazole for the treatment of Helicobacter pylori infection: preliminary results. Ital J Gastroenterol Hepatol 1997; 29(Suppl. 2): A108A108 (Abstract).
  • 11
    Bertoni G, Sassatelli R & Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996; 91: 25863.
  • 12
    Cammarota G, Tursi A & Papa A, et al. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. Aliment Pharmacol Ther 1996; 10: 9971000.
  • 13
    Chey WD, Fisher L & Barnett J, et al. Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 12637.
  • 14
    Vcev A, Stimac D, Ivandic A, Vceva A, Takac B & Pezerovic D. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Aliment Pharmacol Ther 2000; 14: 6972.DOI: 10.1046/j.1365-2036.2000.00662.x
  • 15
    Dal Bo N, Di Mario F & Ferrara M, et al. Azithromycin in a triple therapy for eradicating Helicobacter pylori. Gut 1994; 35(Suppl. 4): A133A133(Abstract).
  • 16
    Vcev A, Vceva A, Stimac D, Takac B, Dmitrovic B & Kovac D. Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients. Aliment Pharmacol Ther 1998; 12: 4536.DOI: 10.1046/j.1365-2036.1998.00332.x
  • 17
    Labenz J, Leverkuss F & Borsch G. Omeprazole plus amoxycillin for cure of H. pylori infection: factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 10705.
  • 18
    Cayla R, Zerbib F, Talbi P, Megraud F & Lamouliatte H. Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995; 37(Suppl.1): A55A55(Abstract).
  • 19
    Labenz J, Gynes E & Ruhl GH. Omeprazole plus amoxycillin: efficacy of various treatment regimens to eradicate H. Pylori. Am J Gastroenterol 1993; 88: 4915.
  • 20
    Bayerdoffer E, Miehlke S & Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure H. pylori infection in patients with duodenal ulcer. Gastroenterology 1995; 108: 14127.
  • 21
    The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 813.
  • 22
    Graham DY, Lew GM & Malaty HM. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 4936.
  • 23
    Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993; 28(Suppl. 196): 347.
  • 24
    Goddard A & Logan R. One week low-dose triple therapy: new standards for Helicobacter pylori treatment. Gut 1994; 35: 3236.
  • 25
    Xia HX, Buckley M & Hyde D, et al. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995; 37(Suppl. 1): A55A55(Abstract).
  • 26
    Krichhoff RM, Laufen H, Schacke G, Kirchhoff G & Gallo E. Determination of azithromycin in gastric biopsy samples. Int J Clin Pharmacol Ther 1999; 37: 3614.
  • 27
    Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991; 91(Suppl. 3A): 40S45S.
  • 28
    Trevisani L, Sartori S & Galvani F, et al. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease. Aliment Pharmacol Ther 1998; 12: 126972.
  • 29
    Annibale B, D’Ambra G & Luzzi I, et al. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients? Am J Gastroenterol 1997; 92: 7904.
  • 30
    Bazzoli F, Zagari RM, Megraud F, Pozzato P & Roda E. Antimicrobial resistance of Helicobacter pylori in a large population of duodenal ulcer patients in Italy. Gastroenterology 2000; 118(Suppl. 2): 26522652.